Figure 8.
Figure 8. STI571 does not reduce expression of SHIP RNA or protein in expanded clones of BCR-ABL–transduced +/+ cells. (A) Top panel shows real-time RT-PCR SYBR Green1 fluorescence versus cycle number of murine SHIP and GAPDH cDNAs prepared from RNAisolated from BCR-ABL–transduced +/+ cells cultured with 0 to 10 μm STI571 for 16 hours. Bottom panel shows the calculated levels of SHIP transcripts (after normalization to GAPDH transcript levels in the same extracts) in each treated clone expressed as a percentage of the SHIP transcript levels in the untreated control. The levels of SHIP transcripts relative to GAPDH in each sample were calculated using the formula described.26 (B) Western analysis of cells from a BCR-ABL–transduced +/+ clone (no. 1) cultured with varying concentrations of STI571 as described in panelA. Antibodies were the same as in panel B of Figure 7.

STI571 does not reduce expression of SHIP RNA or protein in expanded clones of BCR-ABL–transduced +/+ cells. (A) Top panel shows real-time RT-PCR SYBR Green1 fluorescence versus cycle number of murine SHIP and GAPDH cDNAs prepared from RNAisolated from BCR-ABL–transduced +/+ cells cultured with 0 to 10 μm STI571 for 16 hours. Bottom panel shows the calculated levels of SHIP transcripts (after normalization to GAPDH transcript levels in the same extracts) in each treated clone expressed as a percentage of the SHIP transcript levels in the untreated control. The levels of SHIP transcripts relative to GAPDH in each sample were calculated using the formula described.26  (B) Western analysis of cells from a BCR-ABL–transduced +/+ clone (no. 1) cultured with varying concentrations of STI571 as described in panelA. Antibodies were the same as in panel B of Figure 7.

Close Modal

or Create an Account

Close Modal
Close Modal